Expertise in
5
conditions

Gina L. O'grady

Auckland, AUK, NZ 
Expertise in
5
conditions
Auckland, AUK, NZ 

Overview

Gina O'grady practices practicing medicine in Auckland, New Zealand.

Ms. O'grady is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses CHARGE Syndrome, Tubular Aggregate Myopathy, Amyotonia Congenita, and Myotonia Congenita.

She is actively involved in clinical research, co-authoring 34 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Auckland, AUK, New Zealand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of High Doses of Eteplirsen, Preceded by an Open-label Dose Escalation, in Patients With Duchenne Muscular Dystrophy With Deletion Mutations Amenable to Exon 51 Skipping
A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of High Doses of Eteplirsen, Preceded by an Open-label Dose Escalation, in Patients With Duchenne Muscular Dystrophy With Deletion Mutations Amenable to Exon 51 Skipping
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2026
Intervention Type: Drug
Study Drug: Eteplirsen
Study Phase: Phase 3
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Tideglusib Versus Placebo for the Treatment of Children and Adolescents With Congenital Myotonic Dystrophy (REACH CDM)
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Tideglusib Versus Placebo for the Treatment of Children and Adolescents With Congenital Myotonic Dystrophy (REACH CDM)
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Tideglusib
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

34 Total Publications

Epidemiology of spinal muscular atrophy in Aotearoa-New Zealand.
Epidemiology of spinal muscular atrophy in Aotearoa-New Zealand.
Journal: Journal of neuromuscular diseases
Published: March 28, 2025

Frequently Asked Questions about Gina L. O'grady

Is Gina L. O'grady a top-rated expert for CHARGE Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Gina L. O'grady is classified as an Distinguished expert for CHARGE Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gina L. O'grady participate in research or clinical trials?

Yes. Gina L. O'grady has published 34 articles and abstracts on conditions like CHARGE Syndrome. You can view a list of Gina L. O'grady's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. O'grady's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile